ClinicalTrials.Veeva

Menu

Value of Fetal Scalp Lactate Sampling During Labour in Cases of Abnormal Fetal Heart Rate

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Metabolic Acidosis

Study type

Observational

Funder types

Other

Identifiers

NCT05259202
RECHMPL22_0070

Details and patient eligibility

About

ST-analysis of the foetal ECG (STAN®) is another second line technique for intrapartum foetal monitoring. Combining ST-analysis with standard CTG interpretation aims to identify hypoxic foetuses more accurately than CTG alone. The STAN® method identifies changes in the ST-interval of the foetal ECG that occur in the presence of foetalcentral hypoxia The aim of this studie is to investigate if the foetal lactate blood sampling is still useful when STAN® monitoring is already being used as a second line technique for intrapartum foetal monitoring if the fetal heart rate is abnormal without a significant ST event Nowadays in the Montpellier hospital's protocol, the investigators have to check the value of lactate sampling in case of le STAN doesn't detect an ST event.

So this studie can change the Montpellier hospital's protocol and avoid useless fetal blood sampling

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient with labor monitoring by ST segment analysis (STAN) according to current guidelines
  • patient who received a fetal lactate sample for fetal heart rate classified as pathological for more than 60 minutes

Exclusion criteria

  • STAN guidelines not respected before installation and during work
  • misclassification of fetal heart rate
  • obstetrical complications during labor

Trial contacts and locations

1

Loading...

Central trial contact

WALTZING Aude, Resident; DUPORT-PERCIER Marie, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems